Some of the biggest figures in evidence-based medicine got together and did a review of blinding in all kinds of trials of medical drugs, and found that trials with inadequate blinding exaggerated the benefits of the treatments being studied by 17 per cent. Blinding is not some obscure piece of nitpicking, idiosyncratic to pedants like me, used to attack alternative therapies.
